[1] Ruiz-del-Arbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol, 2015,21:11502-11521. [2] Karagiannakis DS, Papatheodoridis G, Vlachogiannakos J. Recent advances in cirrhotic cardiomyopathy. Dig Dis Sci,2015,60:1141-1151. [3] 中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案. 中华内科杂志, 2001,40:62-68. [4] 王丽萍, 张新力. 组织多普勒与脉冲多普勒Tei指数对肝硬化患者左心功能改变的对比研究. 临床超声医学杂志, 2010,12:676-679. [5] Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol, 2014,20:16996-17010. [6] Villa GL, Gentilini P. Hemodynamic alterations in liver cirrhosis. Mol Aspects Med,2008,29:112-118. [7] 李云静, 雷旭, 殷华,等. 关注肝硬化性心肌病. 世界华人消化杂志, 2016, 27:3846-3852. [8] Tandon P, Abraldes JG, Keough A, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics. Clin Gastroenterol Hepatol, 2015,13:1189-1196. [9] Pozzi M, Redaelli E, Ratti L, et al. Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterol Dietol,2005,51:179-186. [10] Wong JLC, Arango-Viana JC, Squires T. Heart, liver and spleen pathology in chronic alcohol and drug users. J Forensic Leg Med, 2008,15:141-147. [11] Silvestre OM, Bacal F, De Souza Ramos D, et al. Impact of the severity of end-stage liver disease in cardiac structure and function. Ann Hepatol,2013, 12:85-91. [12] 孙福荣, 孟一曼, 王炳元,等. 终末期肝病患者终末期肝病模型评分与左心功能的关系. 中华肝脏病杂志, 2010,18:758-762. [13] Oflaz H, Sen F, Bayrakli SK, et al. Reduced coronary flow reserve and early diastolic filling abnormalities in patients with nephrotic syndrome. Ren Fail, 2008,30:914-920. [14] Tei C; Ling LH; Hodge DO,et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. J Cardiol,1995, 26:357-366. [15] 孟素云, 李越, 李岩密,等. 组织多普勒和血流多普勒测量左室Tei指数比较. 中国医学影像学杂志, 2006,14:303-305. |